Blood diffusion to novel therapies: A quantitative analysis of scholarly output in Haemophilia from India

Abstract

Lack of specific protein factors, such as factor VIII and factor IX, results in haemophilia, a genetic bleeding condition. Due to its genetics, haemophilia affects an individual, but we can see how it has an impact on a whole generation. The goal of this study is to determine the extent to which our Indian researchers have been able to advance this highly sought-after field. Although this study was intended to last 75 years, it had to be restricted to the years 1991 to 2021 due to a shortage of publications at the time of data mining. There was a total of 81 publications found, and after analysing them, it was found that India and the USA collaborated more frequently than France and the UK. The National Institute of Immunohaematology (NIIH), located in Mumbai, is India's most productive institution in terms of the number of publications or ongoing work. Haemophilia, factor viii, and gene therapy were the most commonly used keywords. Indian researchers still need to put in a lot of effort in this area because, according to studies from around the world, haemophilia is spreading like a fire. Continuous research and knowledge of the needs of the population are required if we are to improve not only our position in the world but also the way we are treated, which would make life better.